Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Thrombosis Research|July 20, 2005
Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapyYuko Kamikura, Hideo Wada, Tomohiro Sase, et al.
British Journal of Haematology|April 3, 2004
CD21S antigen expression in tumour cells of diffuse large B-cell lymphomas is an independent prognostic factor indicating better overall survivalShoko Ogawa, Motoko Yamaguchi, Kouji Oka, et al.
British Journal of Haematology|June 10, 2008
Gene expression profiling of diffuse large B-cell lymphoma supervised by CD21 expressionKana Miyazaki, Motoko Yamaguchi, Miyuki Suguro, et al.
Cancer Research|January 9, 2003
Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomasTohru Kobayashi, Motoko Yamaguchi, Seungchan Kim, et al.
Japanese Journal of Clinical Oncology|December 16, 2025
Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER)Yusuke Sano, Kana Miyazaki, Motoko Yamaguchi, et al.
Oncogene|October 14, 2004
Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphomaYoshihiro Kameoka, Hiroyuki Tagawa, Shinobu Tsuzuki, et al.
Thrombosis and Haemostasis|January 5, 2005
Haemostatic abnormalities and thrombotic disorders in malignant lymphomaTomohiro Sase, Hideo Wada, Motoko Yamaguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2010
[Aggressive NK-cell leukemia with sustained relapse-free survival after allogeneic peripheral blood stem cell transplantation]Kazuko Ino, Masahiro Masuya, Yoshiki Nakamori, et al.
Genes, Chromosomes & Cancer|November 16, 2004
Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survivalTomoko Yoshioka, Ikuo Miura, Masaaki Kume, et al.
Blood|September 21, 2006
Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5Takuhei Murase, Motoko Yamaguchi, Ritsuro Suzuki, et al.
Pageof 8